Colon Carcinoma clinical trials
52 active trials name this condition. Describe your situation to see which ones you may be eligible for.
Refine by biomarker
By location
- Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer
- Microbiotic Product to Promote Microbiome Health and Improve Chemotherapy Delivery
- Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer
- Single Arm Study of Neoadjuvant Dostarlimab in Stage II and III Deficient Mismatch Repair Colon Cancers
- Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- Phase II Open-label Trial of Neoadjuvant Immunochemotherapy for Resectable Non-metastatic Colon cancER: NICER
- Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment
- Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors
- BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion
- Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
- Brodalumab in the Treatment of Immune-Related Adverse Events
- Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
- Phase II Trial of Lung Chemoemobolization
- Designing a Dyad-Based mHealth Intervention to Improve Adherence to Lifestyle Recommendations in Colorectal Cancer Survivors and Their Family Caregivers
- Imaging of Solid Tumors Using FAP-2286
- An Exosomal microRNA Signature for Preoperative Staging in Colon Cancer
- Chronic Loose Stools Following Right-sided Hemicolectomy for Colon Cancer and the Association With Bile Acid Malabsorption and Small Intestinal Bacterial Overgrowth Using a Novel Sampling Device
- COLON-MD: Colon Cancer Longitudinal Study
- A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
- Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
- Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
- Integrated Cancer Repository for Cancer Research
- Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
- Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
- Collection of Blood From Patients With Cancer
- Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer
- Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases
- Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
- Care Coordination Educational Intervention Study for Patients from Rural Areas with Early Stage Cancer
- Preserving Physical Function in Older Adults With Cancer: Impact of an Optimizing Nutrition Intervention Applied Before and After Surgery
- Distance-Based Exercise to Preserve Function and Prevent Disability
- The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
- Resilience and Equity in Aging, Cancer, and Health (REACH)
- SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors
- Improving Care for Rural Patients With Solid Tumors
- EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
- Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer
- Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry
- Testing Alcohol Cancer Risk Messages
- Reducing Wound Infections Using Bioelectric Wound Dressings
- Postbiotics for Mitigation of Postoperative Dysbiosis in Gastrointestinal Cancer Surgery
- Clinical Trial to Treat Stage IV Cancer Patients
- Quest to Analyze One Thousand Humans Meditating
- The Phoenix Trial: Phase II Trial of Cemiplimab for the Non-operative Management of Localized dMMR Colon Cancer
- A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
- A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors
- Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Colon Carcinoma” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.